A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...

University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...

A recent study found that relatively healthy obesity may reduce the risk of developing Alzheimer's disease. Trump names ...

November is Alzheimer’s Awareness Month. According to the Alzheimer’s Association Mississippi Chapter, nearly 7 million ...

14, joined together for a common cause: raising money to fund Alzheimer’s Association’s classes and resources for local ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

The $74.5 million grant will fund a study focused on an inherited genetic mutation that has been linked to Alzheimer's.

November is Alzheimer’s Awareness Month and New York has the second highest rate of Alzheimer’s disease in the U.S. NYC’s ...

A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...